Hanlon Investment Management, Inc. Charles River Laboratories International, Inc. Transaction History

Hanlon Investment Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$255.51 - $362.11 $1.02 Million - $1.45 Million	-3,994 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$351.38 - $448.68 $23,191 - $29,612	66 Added 1.68%	3,994 $1.51 Million
Q3 2021 Nov 19, 2021	BUY	$372.64 - $458.3 $117,008 - $143,906	314 Added 8.69%	3,928 $1.62 Million
Q2 2021 Aug 10, 2021	BUY	$294.17 - $371.65 $1.06 Million - $1.34 Million	3,614 New	3,614 $1.34 Million

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Hanlon Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hanlon Investment Management, Inc. with notifications on news.